PUSAT DIALISIS SEJATI SUBANG

PUSAT DIALISIS SEJATI SUBANG

  

(Company No. 398471 -PA)

(Incorporated in Malaysia)

MANAGEMENT REPORT AND FINANCIAL STATEMENTS

31 December 2014

MANAGEMENT ACCOUNT

31 December 2014

  (Company No. 398471 -PA) (Incorporated in Malaysia)

CORPORATE INFORMATION

  BOARD OF DIRECTORS : ARSAD BIN RAHMAN TAN KEE KONG

  COMPANY SECRETARY : TAN MOON MENG (LS NO.10004) AUDITORS : YOONG YEE & CO (AXX 1001) PRINCIPAL PLACE OF BUSINESS :

  No. 16 JALAN KELULI AK7/AK, PUSAT PERNIAGAAN BUKIT RAJA, SEKSYEN 7, 40000 SHAH ALAM, SELANGOR

  REGISTERED OFFICE ADDRESS :

  No. 16 JALAN KELULI AK7/AK, PUSAT PERNIAGAAN BUKIT RAJA, SEKSYEN 7, 40000 SHAH ALAM, SELANGOR

  (Company No. 398471 -PA) (Incorporated in Malaysia) DIRECTORS’ REPORT FOR THE ENDED 31 DECEMBER 2014

  The directors hereby submit their management account report together with the financial statements of the Company for the ended 31 December 2014

PRINCIPAL ACTIVITIES

  The principal activities of the Company are to carry business in providing facilities and services in relation to dialysis for patient care. There have been no significant changes in the nature of the activities during the year.

  RESULTS RM

  Profit for the year 55,729.50

  RESERVES AND PROVISIONS There were no material transfers to or from reserves or provisions during the financial year. SHARES AND DEBENTURES

  During the year, the Company has not issue any ordinary shares: The Company did not issue any debentures during the year.

SHARE OPTIONS

  No options have been granted by the Company to any parties during the year to take up unissued shares of the Company.

  DIRECTORS

  The directors who held office since the date of the last report are: ARSAD BIN RAHMAN TAN KEE KONG

  (Company No. 398471 -PA) (Incorporated in Malaysia) DIRE CTORS’ BENEFITS

  During and at the end of the year, no arrangements subsisted to which the Company is a party, with the object or objects of enabling directors of the Company to acquire benefits by means of the acquisition of shares in, or debentures of, the Company or any other body corporate. Since the end of the previous year, no director has received or become entitled to receive a benefit (other than a benefit included in the aggregate amount of emoluments received or due and receivable by the directors shown in the financial statements or the fixed salary of a full-time employee of the Company) by reason of a contract made by the Company or a related corporation with the director or with a firm of which the director is a member, or with a company in which the director has a substantial financial interest.

  DIRECTORS’ INTERESTS

  According to the register of directors’ shareholding, the interests of directors in office at the end of the year in the ordinary shares of the Company are as follows:

  Number of Ordinary Shares of RM1 Each At At 01.04.2013 Bought Sold 30.03.2014 Direct Interest

  ARSAD BIN RAHMAN

  1

  • 1 -

  1 - - TAN KEE KONG

  1 OTHER STATUTORY INFORMATION Before the income statement and the balance sheet of the Company were made out, the directors took reasonable steps: (a) to ascertain that proper action had been taken in relation to the writing-off of bad debts and the making of allowance for doubtful debts, and have satisfied themselves that all known bad debts had been written-off and that adequate allowance had been made for doubtful debts; and

  (b) to ensure that any current assets which were unlikely to be realised at their book values in the ordinary course of business have been written down to their estimated realisable values. As of the date of this report, the directors are not aware of any circumstances: (a) which would render the amount written off for bad debts or the amount of the allowance for doubtful debts inadequate to any substantial extent in the financial statements of the Company; and (b) which would render the values attributed to current assets in the financial statements of the

  Company misleading; (c) which have arisen which render adherence to the existing method of valuation of assets or liabilities of the Company misleading or inappropriate;

  (Company No. 398471 -PA) (Incorporated in Malaysia)

  (d) not otherwise dealt with in this report or financial statements which would render any amount stated in the financial statements of the Company misleading. As of the date of this report, there does not exist: (a) any charge on the assets of the Company which has arisen since the end of the year and secures the liability of any other person; or (b) any contingent liability of the Company which has arisen since the end of the year. No contingent or other liability has become enforceable, or is likely to become enforceable within the period of nine months after the end of the year which, in the opinion of the directors, will or may substantially affect the ability of the Company to meet its obligations as and when they fall due. In the opinion of the directors, no item, transaction or event of a material and unusual nature has arisen in the interval between the end of the year and the date of this report which is likely to affect substantially the results of the operations of the Company for the year.

  AUDITORS / MANAGEMENT ACCOUNT

  The Management account was prepared by auditors, Messrs. YOONG YEE & CO., Signed on behalf of the Board of Directors, PUSAT DIALISIS SEJATI SUBANG

  Director

  Kuala Lumpur Date: 31 December 2014

  (Company No. 398471 -PA) (Incorporated in Malaysia)

CURRENT ASSETS

CURRENT LIABILITIES

NET CURRENT LIABILITIES (281,214.86) (395,522.18)

FINANCED BY: CAPITAL AND RESERVES

  13

  2.00 Accumulated losses 14 (55,782.65) (140,385.85)

  2.00

  Share capital

  BALANCE SHEET AS AT 31 DECEMBER 2014 2014 2013 Note RM RM NON-CURRENT ASSETS

  (55,780.65) (140,383.85)

  465,650.00 554,852.42

  Other payables and accruals 10 108,565.00 195,364.90 Amount due to directors 8 325,798.00 325,798.00

  Trade payables 31,287.00 33,689.52

  184,435.14 159,330.24

  Inventories 5 7,656.00 4,188.50 Trade receivables 6 168,940.00 153,052.00 Other receivables, deposits and prepayments 7 2,389.00 452.36 Cash and bank balances 5,450.14 1,637.38

  Property, plant and equipment 3 225,434.21 255,138.33 225,434.21 255,138.33

CAPITAL DEFICIENCY (55,780.65) (140,383.85)

  PUSAT DIALISIS SEJATI SUBANG (Company No. 398471 -PA) (Incorporated in Malaysia)

DETAILED INCOME STATEMENT FOR THE YEAR ENDED 31 DECEMBER 2014 2014 2013 RM RM

  REVENUE 410,000.00 162,862.00 LESS: COST OF SALES

  Opening inventories 4,188.50 4,213.50 Nephrology fees 10,500.00 10,460.00 Meal for patient 1,345.00 - Purchases 151,700.00 33,957.51

  167,733.50 48,631.01 Less: Closing inventories (9,850.00) (4,188.50)

  157,883.50 44,442.51

  GROSS PROFIT 252,116.50 118,419.49 LESS: OPERATING EXPENSES (196,387.00) (175,210.89)

PROFIT/(LOSS) BEFORE TAX 55,729.50 (56,791.40)

  PUSAT DIALISIS SEJATI SUBANG (Company No. 398471 -PA) (Incorporated in Malaysia)

OPERATING EXPENSES FOR THE YEAR ENDED 31 DECEMBER 2014 2014 2013 RM RM OTHER OPERATING EXPENSES

  Accountancy fees 2,400.00 2,400.00 Astro

  720.00 470.00 Audit fee

  1,500.00 1,500.00 Bank Charges 50.00 320.08 Compensation - 7,900.00 Depreciation of property, plant and equipment 51,000.00 58,750.00 Electricity and water 8,500.00 7,852.86 EPF & SOCSO contribution 7,500.00 6,934.00 Fines and penalty - - Legal fee

  1,000.00 4,000.00 License fee

  345.00 - Petrol ,toll and parking 1,232.00 1,100.00 Printing and stationery 120.00 540.00 Rental of dialysis centre 15,600.00 15,600.00 Salaries, allowances and bonus 61,232.00 58,328.15 Secretarial and filing fees 750.00 810.00 Service tax

  120.00 202.50 SOCSO Contributions 1,210.00 902.45 Staff refreshment

  90.00 Stamping fee - - Tax agent fee - 1,000.00 Telephone charges 1,280.00 433.85 Travelling expenses 2,128.00 903.00 Uniforms

  • Upkeep of dialysis centre 4,500.00 Upkeep of dialysis machine 32,000.00 480.00 Upkeep of office equipment 1,200.00 2,694.00 Wages, incentive and bonus 2,000.00 2,000.00

  196,387.00 175,210.89